Important Safety Notice - Allerject

Please be advised that Sanofi Canada has issued a Precautionary Voluntary Recall for two specific lots of Allerject 0.15 mg / 0.15 mL (pediatric) epinephrine injection, distributed as of June 1, 2015. Full details, as well as instructions on what to do if you have one of these lots, can be found here: http://sanoficanada.mediaroom.com/2015-06-13-Voluntary-Product-Recall-2-Lots-of-Allerject-0-15-mg-0-15-mL-epinephrine-injection-distributed-as-of-June-1-2015 Sanofi is committed to the safety, health and well-being of patients and consumers using its products. Follow us on Twitter @Allerject, @SanofiCanada or visit www.sanofi.ca to stay abreast of developments. Sincerely, Allerject Team


Translate »